Skip to content
★ Sign in to follow
SD Biosensor, Inc. logo

SD Biosensor, Inc. Stock: price and insider trades · South Korea

에스디바이오센서

KR·Mcap ₩758.4BHealth Care

No insider purchase over the last 90 days. The latest, by 김근영, was filed 24 Mar 2026.

Insider Decl.
86
Thresholds
n/a
Buy Volume
€3M
67 ops. · all time
Sell Volume
€22M
13 ops. · all time

Who traded when

BuySale
조영식3 buys
김석규2 buys
고종관1 buy
김병수1 buy
김주한1 buy
민의기1 buy

+8 other insiders

Since the insiders bought

  • Filed 24 Mar 2026 · 230 days ago · €27k
    -20.1%
    Entry ₩7,930 · Close 30 Oct 2026 ₩6,340
  • Filed 24 Mar 2026 · 230 days ago · €28k
    -20.1%
    Entry ₩7,930 · Close 30 Oct 2026 ₩6,340
  • Filed 24 Mar 2026 · 230 days ago · €29k
    -20.1%
    Entry ₩7,930 · Close 30 Oct 2026 ₩6,340

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 18,752 of 26,913 companies
38.4
score / 100
Value
50
Quality
27
FCF yld38%
Earn yld-65%
EV/EBITDA·
ROE-27%
Gross mgn46%
Net mgn-72%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩6,340
Analyst consensus
·
Income statement
Revenue₩710.6B
Gross profit₩325.5B46% margin
EBITDA-₩675.6B-95% margin
Net income-₩512.1B-98.7% margin
Valuation
Beta0.70
Balance sheet & cash
Market cap₩758.4B
Total debt₩669B
Free Cash Flow₩300B
Debt / Equity12%
Profitability & ownership
ROE-26.9%
ROA-1.2%
% insiders72.8%
% institutions2.4%
Last declaration on 12 August 2026
Declarations88 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▼
    상무Executives(filed)
    €68kest.0DART
    17,000 sharesShareKRXDART:20260812000473
  • ▲
    이사Executives
    €28kest.0DART
    6,391 sharesShareKRXDART:20260324000823
    Canonical exit: 22 Sept 2024 (T+90)
  • ▲
    이사Executives
    €27kest.0DART
    6,190 sharesShareKRXDART:20260324000829
    Canonical exit: 21 Jun 2026 (T+90)
  • ▲
    이사Executives
    €28kest.0DART
    6,194 sharesShareKRXDART:20260324000786
    Canonical exit: 18 Jun 2026 (T+90)
  • ▲
    이사Executives
    €29kest.0DART
    6,416 sharesShareKRXDART:20260324000803
    Canonical exit: 18 Jun 2026 (T+90)
  • ▲
    이사Executives
    €27kest.0DART
    6,201 sharesShareKRXDART:20260324000790
    Canonical exit: 21 Jun 2026 (T+90)
  • ▲
    이사Executives
    €27kest.0DART
    6,202 sharesShareKRXDART:20260324000777
    Canonical exit: 21 Jun 2026 (T+90)
  • ▲
    이사Executives
    €27kest.0DART
    6,202 sharesShareKRXDART:20260324000810
    Canonical exit: 21 Jun 2026 (T+90)
  • ▲
    상무Executives
    €15kest.0DART
    3,502 sharesShareKRXDART:20260324000736
    Canonical exit: 21 Jun 2026 (T+90)
  • ▲
    상무Executives
    €45kest.0DART
    9,993 sharesShareKRXDART:20260324000683
    Canonical exit: 18 Jun 2026 (T+90)
  • ▲
    상무Executives
    €46kest.0DART
    10,175 sharesShareKRXDART:20260324000758
    Canonical exit: 18 Jun 2026 (T+90)
  • ▲
    이사Executives
    €28kest.0DART
    6,233 sharesShareKRXDART:20260324000750
    Canonical exit: 18 Jun 2026 (T+90)
  • ▲
    상무Executives
    €43kest.0DART
    10,000 sharesShareKRXDART:20260324000674
    Canonical exit: 21 Jun 2026 (T+90)
  • ●
    Executives
    0DART
    0KRXDART:20260319000920
  • ▲
    부회장Executives
    153M KRW31DART
    20,000 shares@ ₩7,640.000.020% mcap100.0% of flowShareKRXDART:20260316000609
    Canonical exit: 7 Jun 2026 (T+90)
  • ▲
    회장Executives
    2B KRW42DART
    299,549 shares@ ₩7,650.38370.31% mcap93.4% of flowShareKRXDART:20260316000538
    Canonical exit: 9 Jun 2026 (T+90)
  • ▲
    Executives
    €1.3M10DART
    299,549 shares0.28% mcap100.0% of flowKRXDART:20260316000452
    Canonical exit: 7 Jun 2026 (T+90)
  • ▲
    Executives
    €95k3DART
    20,000 shares0.022% mcap6.6% of flowKRXDART:20260311004400
    Canonical exit: 2 Jun 2026 (T+90)
  • ▲
    상무Executives(filed)
    €31kest.0DART
    5,142 sharesShareKRXDART:20250903000118
    Canonical exit: 2 Dec 2025 (T+90)
  • ▲
    Executives
    €204kest.0DART
    28,547 sharesKRXDART:20241126000768
    Canonical exit: 17 Feb 2025 (T+90)
  • ▼
    Executives
    €356kest.0DART
    50,400 sharesKRXDART:20241126000139
  • ▲
    상무Executives
    0DART
    ShareKRXDART:20231228000201
    Canonical exit: 25 Mar 2024 (T+90)
  • ▼
    Executives
    €400kest.0DART
    50,400 sharesKRXDART:20231228000204

25 of 88 declarations

About SD Biosensor, Inc.

In March 2026, 13 distinct filers bought between March 4 and March 23 at SD Biosensor, Inc. (에스디바이오센서). 조영식, 회장, signs the three largest purchases there: EUR 1,338,332 on March 11, EUR 1,323,887 on March 9 and EUR 94,725 on March 4. Only 4 purchases in the record carry an amount, EUR 2,845,568 in all with a median of EUR 709,306.

The full history holds 86 filings, 67 purchases and 13 sales, or 84% purchases among open-market trades. 김석규, 상무, is the most active filer with 51 filings, all purchases; 조영식 has 13, of which 4 purchases and 8 sales. No sale carries an amount.

Read moreShow less

At this South Korean health care company, with a market capitalisation of KRW 811 billion, insiders hold 72.8% of the capital. Filings go from 30 in 2021 to 2 in 2024 and one in 2025, then 18 in 2026. For 65 purchases a 90-day result is stored: a median of minus 16.7%, with 12% of results positive. These are recorded past results, not a forecast.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations